Heming Li

1.6k total citations
60 papers, 1.1k citations indexed

About

Heming Li is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Heming Li has authored 60 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 19 papers in Molecular Biology and 12 papers in Cancer Research. Recurrent topics in Heming Li's work include Cancer Cells and Metastasis (9 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Immunotherapy and Immune Responses (5 papers). Heming Li is often cited by papers focused on Cancer Cells and Metastasis (9 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Immunotherapy and Immune Responses (5 papers). Heming Li collaborates with scholars based in China, United States and Hong Kong. Heming Li's co-authors include Mingfang Zhao, Yunpeng Liu, Xiujuan Qu, Izhar Singh Batth, Ling Xu, Ruoyu Wang, Hyangsoon Noh, Shulin Li, Qing H. Meng and Xiaohong Li and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Heming Li

56 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heming Li China 19 506 475 325 192 150 60 1.1k
Moo Jun Baek South Korea 20 532 1.1× 492 1.0× 245 0.8× 196 1.0× 174 1.2× 87 1.3k
Donghai Huang China 24 815 1.6× 380 0.8× 377 1.2× 138 0.7× 144 1.0× 60 1.3k
Dongjun Jeong South Korea 21 798 1.6× 528 1.1× 294 0.9× 268 1.4× 202 1.3× 55 1.6k
Kathleen E. DelGiorno United States 13 558 1.1× 628 1.3× 323 1.0× 148 0.8× 176 1.2× 26 1.2k
Joshua J. Souchek United States 16 462 0.9× 326 0.7× 245 0.8× 201 1.0× 99 0.7× 22 1.0k
Johanna Tuomela Finland 19 537 1.1× 327 0.7× 179 0.6× 174 0.9× 188 1.3× 49 984
Serena Mancarella Italy 17 507 1.0× 312 0.7× 262 0.8× 120 0.6× 146 1.0× 27 1.1k
Yao Yuan China 20 855 1.7× 500 1.1× 376 1.2× 185 1.0× 174 1.2× 72 1.6k
Jennifer A. Roth United States 14 662 1.3× 406 0.9× 222 0.7× 117 0.6× 112 0.7× 47 1.2k

Countries citing papers authored by Heming Li

Since Specialization
Citations

This map shows the geographic impact of Heming Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heming Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heming Li more than expected).

Fields of papers citing papers by Heming Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heming Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heming Li. The network helps show where Heming Li may publish in the future.

Co-authorship network of co-authors of Heming Li

This figure shows the co-authorship network connecting the top 25 collaborators of Heming Li. A scholar is included among the top collaborators of Heming Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heming Li. Heming Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Yining, Xin Li, Yuchong Zhang, et al.. (2025). The 3PM transformation potential of minimal residual disease in solid tumor management: a bibliometric analysis and review. The EPMA Journal. 16(3). 669–688.
3.
Xie, Wenlian, et al.. (2024). Imidacloprid-induced lung injury in mice: Activation of the PI3K/AKT/NF-κB signaling pathway via TLR4 receptor engagement. The Science of The Total Environment. 931. 172910–172910. 9 indexed citations
4.
Li, Heming, Lu Xu, Tao Han, et al.. (2024). Exploring new frontiers: cell surface vimentin as an emerging marker for circulating tumor cells and a promising therapeutic target in advanced gastric Cancer. Journal of Experimental & Clinical Cancer Research. 43(1). 129–129. 11 indexed citations
5.
Li, Xin, et al.. (2024). FGL1: a novel biomarker and target for non-small cell lung cancer, promoting tumor progression and metastasis through KDM4A/STAT3 transcription mechanism. Journal of Experimental & Clinical Cancer Research. 43(1). 213–213. 4 indexed citations
6.
Li, Xin, et al.. (2024). Immune checkpoint inhibitors rechallenge in non-small cell lung cancer: Current evidence and future directions. Cancer Letters. 604. 217241–217241. 21 indexed citations
7.
Xu, Lu, Sha Shi, Xin Li, et al.. (2024). Intercellular adhesion molecule-1 (ICAM-1): From molecular functions to clinical applications in cancer investigation. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1879(6). 189187–189187. 13 indexed citations
8.
Shen, Yi, Heming Li, Tianwen Ye, et al.. (2024). Morinda officinalis iridoid glycosides, as an inhibitor of GSK-3β, alleviates rheumatoid arthritis through inhibition of NF-κB and JAK2/STAT3 pathway. Frontiers in Pharmacology. 15. 1435274–1435274. 2 indexed citations
9.
Ji, Yin, et al.. (2023). Super-hydrophilic sulfonate-modified covalent organic framework nanosheets for efficient separation and enrichment of glycopeptides. Journal of Chromatography A. 1699. 464020–464020. 12 indexed citations
10.
Li, Zhaoting, Yueyang Deng, Honghao Sun, et al.. (2023). Redox modulation with a perfluorocarbon nanoparticle to reverse Treg-mediated immunosuppression and enhance anti-tumor immunity. Journal of Controlled Release. 358. 579–590. 17 indexed citations
11.
Li, Heming, et al.. (2023). Multikinase inhibitor-based immunotherapy doublet for advanced hepatocellular carcinoma: its efficacy still needs to be determined. HepatoBiliary Surgery and Nutrition. 12(3). 468–471. 1 indexed citations
12.
Wang, Guangtian, Zhihui Li, Huishu Zhang, et al.. (2023). Knockdown of Smox protects the integrity of the blood-brain barrier through antioxidant effect and Nrf2 pathway activation in stroke. International Immunopharmacology. 126. 111183–111183. 4 indexed citations
13.
Li, Heming, et al.. (2023). Progress on the hippocampal circuits and functions based on sharp wave ripples. Brain Research Bulletin. 200. 110695–110695. 3 indexed citations
14.
Xu, Lu, et al.. (2022). SMARCA4: Current status and future perspectives in non-small-cell lung cancer. Cancer Letters. 554. 216022–216022. 58 indexed citations
15.
Liang, Shanshan, Gang Wang, Xuening Ji, et al.. (2020). The prognostic role of a combined fibrinogen and inflammation- based index in patients with metastatic breast cancer. Translational Cancer Research. 9(11). 7065–7078. 7 indexed citations
16.
Liu, Guangyan, Min Xie, Ming Zhao, et al.. (2019). IGF-1R Inhibition Suppresses Cell Proliferation and Increases Radiosensitivity in Nasopharyngeal Carcinoma Cells. Mediators of Inflammation. 2019. 1–9. 20 indexed citations
17.
Li, Heming, Qing H. Meng, Hyangsoon Noh, et al.. (2017). Detection of circulating tumor cells from cryopreserved human sarcoma peripheral blood mononuclear cells. Cancer Letters. 403. 216–223. 28 indexed citations
18.
Zhang, He, et al.. (2015). Application of 3D printer in making individual orbital model. 37(2). 102–106. 1 indexed citations
19.
Li, Heming, Ling Xu, Ce Li, et al.. (2014). Ubiquitin ligase Cbl-b represses IGF-I-induced epithelial mesenchymal transition via ZEB2 and microRNA-200c regulation in gastric cancer cells. Molecular Cancer. 13(1). 136–136. 72 indexed citations
20.
Zhou, Shaobing, Xueyan Liao, Xiaohong Li, Xianmo Deng, & Heming Li. (2003). Poly-d,l-lactide–co-poly(ethylene glycol) microspheres as potential vaccine delivery systems. Journal of Controlled Release. 86(2-3). 195–205. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026